Bioterrorism

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INTRODUCTION

• Current & Future Analysis
• Market Overview

2. UNDERSTANDING BIOTERRORISM

• A Brief Historic Account on Bioterrorism
• Why Biological Agents?
• An Ideal Biological Weapon Candidate
• Bioterrorism is Easy: The Myth!
• Biological Agents/Diseases with Potential for Biological Warfare
• Properties of Biological Agents with Potential for Use as Weapons of Mass Destruction
• Anthrax
• The Anthrax History
• Types of Anthrax
• Inhalational Anthrax
• Cutaneous Anthrax
• Gastrointestinal Anthrax
• The Anthrax Symptoms, Treatment, and Vaccination
• Smallpox
• The Smallpox History
• Plague
• The Plague History
• Types of Plague
• Bubonic Plague
• Pneumonic Plague
• Botulism
• Tularemia
• The Tularemia History
• Viral Hemorrhagic Fevers
• Ebola Hemorrhagic Fever
• Marburg Hemorrhagic Fever
• Lassa Hemorrhagic Fever
• Q Fever
• Brucellosis
• Ricin
• Others

3. MODES OF DELIVERY

• Aerosol Dissemination
• Water Contamination
• Food Contamination
• Insect Vectors
• Other

4. BIOTERRORISM DEFENSE PRODUCTS AND DETECTION EQUIPMENT

• Detection Equipment
• Point Detection Systems
• Standoff Detection Systems
• Passive Standoff Detection Systems
• Defense Products
• Vaccines
• Personal Protective Equipment

5. RECENT INDUSTRY ACTIVITY

• Sanofi Pasteur Acquires Acambis
• PharmAthene Acquires Avecia Biodefense Vaccines Business
• ICx Technologies Completes S3I Acquisition
• Johnson & Johnson to Acquire Omrix
• Emergent BioSolutions Enters into Joint Venture with Ninebio Sdn Bhd
• Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU
• Universal Detection and Kadinuo Sign Agreement
• PharmAthene Signs Marketing Pact with Medison for Israeli Market
• PharmAthene Forms Alliance with Panacea Biotec
• Innovative Biosensors and Universal Detection Plan Collaboration
• Acambis Wins Government Contract for ACAM2000(tm) Smallpox Vaccine
• Crucell, Integrated BioTherapeutics Win NIAID Funding for Vaccine Development
• Universal Detection Secures Repeat Order for Biodetection Kits
• Universal Detection Secures Repeat Order for Biodetection Training Equipment
• Universal Detection Secures and Completes Contract
• Hawaii Emergency Medical Services Orders Simulation and Bio-Detection Kits
• IR BioSciences Raises Financing for Drug Development
• AVI BioPharma Files IND for Marburg
• ICx Technologies Completes GHC Technologies Acquisition
• NanoSensors to Acquire DKL International
• Allen-Vanguard to Acquire Hazard Management Solutions
• PharmAthene Announces Reverse Merger to Acquire Healthcare Acquisition
• CytoGenix Enters into CRADA with USAMRIID
• Advanced Life Sciences Announces Collaboration with NIAID
• U.S. BioDefense to Receive Exclusive License from Shine Holdings
• Emergent BioSolutions Signs Agreement to License VaxImmune
• Universal Detection Signs Distribution Agreement with ADVNT
• Universal Detection Secures Gulf Security Order for Detection Kits
• Dycor Technologies Wins Rheinmetall Landsystems Contract
• AVI BioPharma Secures Bioterrorism Response Therapies Contracts
• Emergent BioSolutions Wins HHS Anthrax Biodefense Contract
• Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from NIAID/ BARDA
• SRI International Secures Contract for Anti-Biological Threat Drugs from DTRA
• Universal Detection Completes Foot Locker Order for Bioterrorism Detection Kits
• PharmAthene Wins HHS Biodefense Contract
• Ibis Biosciences Receives Four New Contracts from Government
• Universal Detection Receives Guaranteed Order from SSI
• Ichor Receives Navy Contract for Vaccine Development
• PharmAthene Receives Contract to Develop Anthrax Anti-Toxin
• General Dynamics Canada Secures Contract from Canadian Forces
• Universal Detection Commences R&D for Portable Anthrax Detector
• BioFactura Completes Initial Clinical Testing

6. PRODUCT LAUNCHES

• Smiths Detection Introduces SmartBio(tm) Biological Agents Detector
• Safe Life Launches Triosyn Disposable Respirators
• ICx Unveils Integrated System for CBR Threat Detection, SafeAir(tm)
• Innovative Biosensors Unveils BioFlash Biological Detector
• Lawrence Laboratory Develops Biological, Chemical Agent Detection Machine

7. FOCUS ON SELECT PLAYERS

• Acambis Plc (UK)
• AVI BioPharma, Inc. (USA)
• Blucher Gmbh (Germany)
• Evogen, Inc. (USA)
• Human Genome Sciences Inc. (USA)
• ICX Technologies, Inc. (USA)
• ILC Dover LP (USA)
• Medarex, Inc. (USA)
• Northrop Grumman Corporation (USA)
• PharmAthene, Inc. (USA)
• Scott Health & Safety (USA)
• Smiths Detection (USA)
• The Baker Company (USA)
• Universal Detection Technology (USA)

8. GLOBAL MARKET PERSPECTIVE

• Table 1: World Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment by Geographic Region - US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 2: World Historic Review for Bioterrorism Detection Equipment by Geographic Region - US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2001 through 2015 (includes corresponding Graph/Chart)
• Table 3: World 10-Year Perspective for Bioterrorism Detection Equipment Market by Geographic Region - Percentage Share Breakdown of Dollar Revenue for US, Europe, Asia (Including Japan), and Middle East Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

• A. Market Analysis
• A Case of Undue Importance
• Market Drivers
• Market Dampers
• Investment Bottlenecks
• Legislative Bottlenecks
• Government Biodefense Funding
• The Federal Biological Weapons Prevention and Defense Funding
• Table 4: The US Federal Government Spending on Bioweapons Prevention and Defense - Allocation of Funds in US$ Million by Department/Agency from FY2001 to FY2007 (includes corresponding Graph/Chart)
• Table 5: The US Federal Government Spending on Bioweapons Prevention and Defense - Percentage Share Breakdown of Funds Allocation by Department/Agency for FY2001 and FY2007 (includes corresponding Graph/Chart)
• Table 6: The US Federal Funding for the Department of Health and Human Services by its Constituent Agencies and Offices in US$ Million from FY2001- FY2007 (Including Requested Funding for the Year 2007) (includes corresponding Graph/Chart)
• The RDT&E Biodefense Funding
• Table 7: Biodefense Funding for Research, Development, Testing and Evaluation (RTD&E) by Agency/Department in US$ Million from FY2001 to FY2007
• Biodefense Prevention Funding
• Table 8: Federal Biodefense Prevention Funding in US$ Million from FY2001 to FY2007 (includes corresponding Graph/Chart)
• Recent Awards for Biodefense Preparedness
• Government Biodefense Initiatives
• Project BioShield
• Pandemic and All-Hazards Preparedness Act
• Public Health Security and Bioterrorism Preparedness and Response Act
• Government Departments / Agencies
• The Department of Health and Human Services
• The National Institutes of Health
• The Centers for Disease Control and Prevention
• The CDC Classification
• The CDC Regulated Shipment Agents
• The Department of Defense
• B. Market Analytics
• Table 9: US Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 10: US Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)
• Table 11: US Recent Past, Current & Future Analysis for Bioterrorism Vaccines Market - Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 12: US Historic Review for Bioterrorism Vaccines Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

2. EUROPE

• Market Analysis
• Table 13: European Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 14: European Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

3. ASIA

• A. Market Analysis
• ASEAN and Canada Forge Ties to Combat Bioterrorism
• China Plans Counter-bioterrorism Security System
• B. Market Analytics
• Table 15: Asian Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 16: Asian Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

4. THE MIDDLE EAST

• Market Analysis
• Table 17: The Middle East Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
• Table 18: The Middle East Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE